Veratis Advisors’s Johnson & Johnson JNJ Stock Holding History

Veratis Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$237K	Buy	+973	New	+$192K	0.19%	71

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Veratis Advisors's JNJ Position: Q4 2025 in Review

Veratis Advisors opened a new position in Johnson & Johnson (JNJ) in Q4 2025: 973 shares worth $237K. The stake represents 0.19% of the portfolio and ranks #71 among its holdings.

4,539 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Veratis Advisors held 973 shares of Johnson & Johnson worth $237K as of Q4 2025.
Johnson & Johnson was a new Veratis Advisors position in Q4 2025.
Johnson & Johnson made up 0.19% of Veratis Advisors's portfolio in Q4 2025, its #71 holding.
4,539 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Veratis Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.